RecruitingNCT06351605
A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (GLOBALIGHT)
Phase not reported · 500 planned enrolment
- Countries listed
- 2
- Registry update
- September 22, 2026
immortal.lifePublic trial registrations naming LumiThera, Inc. as an industry lead sponsor.
This is an independent registry-name view, not a verified corporate profile, portfolio valuation, ownership map, endorsement, or investment recommendation.
This does not mean that no transaction exists. A record appears only after its disclosure source and the connection to this exact registry sponsor identity are separately verified.
Phase not reported · 500 planned enrolment